OxiWear

Overview
News
Wearable Tech?
Product stageSegments
Minimum Viable Product
?
Wearable medical devices
?

OxiWear is a company that has developed an innovative ear-wearable device for continuous monitoring of oxygen saturation levels and vital signs. The device, launched in 2022, is designed to track blood oxygen levels in real-time during physical activity or motion. It provides proactive alerts when oxygen levels drop below safe thresholds, allowing users to take timely action and prevent potential hypoxic injuries.

The OxiWear device is worn on the ear's helix, featuring a sleek, lightweight, and water-resistant design. It offers adjustable clip-on mechanisms and interchangeable faceplate color options, enabling users to personalize their style. The device is paired with a mobile app that displays real-time insights through a customizable dashboard, allowing users to track progress, make notes, and set personalized alerts.

OxiWear's primary target market includes individuals prone to hypoxia due to chronic conditions such as pulmonary hypertension, COPD, cystic fibrosis, pulmonary fibrosis, and long-COVID. Additionally, the device caters to extreme and high-performance athletes in sports involving high cardiovascular exertion or high-altitude training, where they are at risk of hypoxic injuries.

OxiWear began shipping its consumer devices in December 2022, having raised approximately USD 3 million in funding earlier that year. The company has obtained trademarks and patents in the US and Southeast Asia and is currently conducting beta testing while working toward obtaining FDA approvals.

Key customers and partnerships

OxiWear has established partnerships with notable organizations in the sports and athletic realm. In March 2022, the company signed a memorandum of understanding with Gibraltar-based E.P. Global Events Limited, owner of the World's Highest OCR (Obstacle Course Racing) and ALTITUDE OCR World Series, World Finals, and World Championships. These events involve altitude trekking ascents, obstacle courses, and endurance distance races on Mount Everest, Mount Kilimanjaro, and other extreme altitude locations worldwide. OxiWear's devices are used to detect and prevent life-threatening medical conditions caused by hypoxia during these events.

Furthermore, OxiWear's devices are trusted and utilized by top athletes and teams. As of October 2023, the company works with some extreme athletes, including Red Bull athletes, who use the device for endurance training. OxiWear also collaborates with training centers that train Tour de France cyclists, enabling them to monitor their oxygen levels during intense cycling sessions. Additionally, the company works with high-cardio athletes in sports like soccer, ensuring they maintain their performance levels during the off-season by tracking their oxygen saturation.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
1111 Arlington Blvd Apt 305 Arlington VA USA
Founded year:
2019
Employees:
1-10
IPO status:
Private
Total funding:
USD 4.5 mn
Last Funding:
USD 50.0 k (Grant; Oct 2024)
Last valuation:
USD 5.2 mn (Dec 2019)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.